HH 325 (Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg)
Pill imprint HH 325 has been identified as Hydrochlorothiazide and irbesartan 12.5 mg / 150 mg.
Hydrochlorothiazide/irbesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/irbesartan 12.5 mg / 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- HH 325
- Strength:
- 12.5 mg / 150 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Solco Healthcare US, LLC
More about hydrochlorothiazide/irbesartan
Consumer resources
- Irbesartan/hydrochlorothiazide
- Hydrochlorothiazide and irbesartan
- Irbesartan and hydrochlorothiazide (Advanced Reading)
- Other brands: Avalide
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
